Publications

5600 Results

Association of Baseline Measures of Socioeconomic Deprivation and Healthcare Utilization in Patients Enrolled in SWOG Cancer Clinical Trials

Authors
D Hershman;R Vaidya;C Till;W Barlow;M LeBlanc;S Ramsey;J Unger
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 6527); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Cancer Care Delivery

SWOG S1823/CCTG GCC1 - Translational Observational Investigational Study of the Liquid Biomarker microRNA 371a-3p in Newly Diagnosed Germ Cell Tumours - Real-World Trial Design, Rapid Accrual, and Robust Secondary Use of Data Opportunities

Authors
A Morin Coulombe;G Ozgun;R Johnson;M Lewis;N Adra;S Eggener;B Roth;C Ryan;C Porter;F Millard;T Jang;R Hamilton;L Einhorn;C Kollmannsberger;K Arnold;C Blanke;S Daneshmand;A Harzstark;C Nichols;L Nappi
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS5103); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), TIP poster session
Year
2023
Research Committee(s)
Genitourinary, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S1823

Impact of COVID-19 Pandemic Mitigation Strategies on Industry and NCI Cancer Treatment Trials

Authors
J Unger;C Schenkel;H Stires;L Levit;M Stewart;B Mckelvey;B Canin;E Dressler;K Flaherty;P Fredette;L Jones;M McCann;T Miller;A Onitilo;F Palmieri;T Patel;R Paul;G Smith;S Bruinooge;A Alva
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 1565); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Cancer Care Delivery

Adjuvant everolimus in patients (Pts) with localized non-clear cell renal cell carcinoma (RCC): Subgroup analysis from the Everest trial (SWOG S0931)

Authors
S Gulati;C Tangen;C Ryan;U Vaishampayan;B Shuch;P Barata;D Pruthi;C Bergerot;A Tripathi;IM Thompson;P Lara;S Pal
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 4546); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S0931

Adjusted indirect treatment comparison of progression-free survival (PFS) associated with DRd and VRd based on MAIA and SWOG S0777 individual patient-level data

Authors
B Durie;S Kumar;E Ammann;A Fu;S Kaila;A Lam;S Usmani;T Facon
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 8037); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster
Year
2023
Research Committee(s)
Myeloma
Study Number(s)
S0777

Diversity, equity, and inclusion (DEI) champions: Lessons learned and implications for future programming to support cancer clinical trials

Authors
C Figueroa-Moseley;L Gansauer;J McDermott;M Espinoza Gutarra;G Nagaraj;P Robinson;R Bangs;A Caban-Holt
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr e18529); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), publication only
Year
2023
Research Committee(s)
Cancer Care Delivery

Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC)

Authors
S Halabi;A Roy;S Guo;L Rydzewska;P Godolphin;M Hussain;C Tangen;IM Thompson;W Xie;M Carducci;M Smith;M Morris;G Gravis;D Dearnlavey;P Verhagen;T Goto;J Tierney;N James;M Buyse;C Sweeney
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5070); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

The relationship between a priori defined prognostic risk groups and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC)

Authors
H Halabi;A Roy;S Guo;L Rydzewska;P Godolphin;M Hussain;C Tangen;IM Thompson;M Carducci;M Smith;M Morris;G Gravis;D Dearnlavey;P Verhagen;T Goto;J Tierney;N James;N James;M Buyse;C Sweeney
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5073); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor (FUT2) genotype, but not Lewis antigen (FUT3) genotype

Authors
J Kim;C Yuan;L Amundadottir;B Wolpin;A Klein;H Risch;P Kraft;Panc Ca Consort (P Goodman)
Journal / Conference
Cancer Epidemiology, Biomarkers, and Prevention Sep 1;32(9):1242-1248
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37342060
PMC
PMC10527950
Study Number(s)
S0000

A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk

Authors
E Aglago;A Kim;Y Lin;C Qu;M Evangelou;Y Ren;J Morrison;D Albanes;V Arndt;E Barry;J Baurley;S Berndt;S Bien;D Bishop;E Bouras;H Brenner;D Buchanan;A Budiarto;R Carreras-Torres;G Casey;T Cenggoro;A Chan;J Chang-Claude;X Chen;D Conti;M Devall;N Dimou;D Drew;J Figueiredo;S Gallinger;G Giles;S Gruber;A Gsur;M Gunter;H Hampel;S Harlid;A Hidaka;T Harrison;M Hoffmeister;J Huyghe;M Jenkins;K Jordahl;A Joshi;E Kawaguchi;T Keku;A Kundaje;S Larrson;L LeMarchand;J Lewinger;B Lynch;B Mahesworo;M Mandic;M Obon-Santacana;M Moreno;N Murphy;H Nan;R Nassir;P Newcomb;S Ogino;J Ose;R Pai;J Palmer;N Papadimitriou;B Pardamean;A Peoples;E Platz;J Potter;R Prentice;G Rennert;E Ruiz-Narvaez;L Sakoda;P Scacheri;S Schmidt;R Schoen;A Shcherbina;M Slattery;M Stern;Y Su;C Tangen;S Thibodeau;D Thomas;Y Tian;C Ulrich;F van Duijnhoven;B Van Guelpen;K Visvanathan;P Vodicka;J Wang;E White;A Wolk;M Woods;H Wu;N Zemlianskaia;L Hsu;W Gauderman;U Peters;K Tsilidis;P Campbell
Journal / Conference
Cancer Research Aug 1;83(15):2572-2583
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID37249599
PMC
PMC10391330
Study Number(s)
S0000